Responsibility is part of our businessColoplast began as a small company in Denmark nearly sixty years ago. Today, we employ over 7,500 people and are represented in 55 countries around the world.
By acting responsible and setting a new standard of care in the many markets we're present in, we drive growth for the business while at the same time live by our mission: to make life easier for people with intimate healthcase needs. Latest Responsibility Report
CR-report 2010/2011
CR-report 2009/2010
CR-report 2008/2009
UN Global CompactOur commitment to honour our responsibilities is underlined by our active membership of the UN’s Global Compact. Our recent Communications on Progress to Global Compact include: PoliciesCorporate responsibility in Coloplast is guided by a set of policies and positions, which describe our way of doing business. General policies include: Phthalates policy May 2011
Phthalates are commonly used in medical devices as softeners in PVC plastics. There are concerns, however, that phthalates may in some cases pose adverse risks to human health and the environment, both individually and through cumulative exposure from their presence in multiple everyday use products. Coloplast recognizes these concerns and we therefore choose to proactively and continuously limit the use of phthalates in our products. We are especially cau-tious regarding the use of phthalates in products designed for people who are particularly sensitive to their effects; e.g. children and pregnant or breast-feeding women.
Phthalates are now found only in some of Coloplast’s older Continence Care products, and we intend to continue limit-ing their use: - We do not use phthalates in any new products.
- We highly prioritize to substitute phthalates when we modify existing products.
- We will continuously reduce the number of items in our existing product portfolio containing phthalates.
- We set targets for reducing the amount of phthalates used in Coloplast products.
- We strive to offer phthalate-free alternatives to all product families containing phthalates.
Coloplast also proactively shares our knowledge regarding the use and reduction of phthalates in medical devices and we clearly inform our customers regarding the content of phthalates in our products. We also regularly report on our progress in limiting the use of phthalates. Coloplast welcomes and supports an international ban against the use of phthalates in medical devices.
Reduction Target:
Every second urine bag sold is phthalate free before 1th of October 2014.
Furthermore, our consumption of phthalates compared to the continence care revenue is to decrease by 30% per 1th of October 2014 with 2009/10 as base year. We openly communicate about current products containing phthalates and suggest phthalate-free alternatives whe this is possible. Whistleblower hotlineColoplast has established a so-called whistleblower hotline. Employees, Board members and business partners can report suspected serious violations or concerns regarding financial wrongdoings. Outside the EU, a broader range of topics may be reported. You are encouraged to identify yourself, but the hotline does offer the possibility of remaining anonymous.
|